Wall Street Analistleri, İnşaatçıların İlk Kaynak Stokunun Yükseleceğini mi yoksa Batacağını mı Tahmin Ediyor?

Are Wall Street Analysts Predicting Builders FirstSource Stock Will Climb or Sink?

Fri, August 14, 2026 at 1:52 PM GMT+3 2 min read

• BLDR -1.43%
• ^GSPC -0.17%

Builders FirstSource, Inc. (BLDR), based in Irving, Texas, manufactures and supplies building materials, manufactured components, and construction services to professional homebuilders, sub-contractors, remodelers, and consumers. Valued at $7.8 billion by market cap, the company has approximately 570 distribution and manufacturing locations, a presence in 43 states, and 90 of the top 100 Metropolitan Statistical Areas.

Shares of building products supplier giant have considerably underperformed the broader market over the past year. BLDR has declined 49.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.6%. In 2026, BLDR stock is down 28.5%, compared to the SPX's 13.9% rise on a YTD basis.

More News from Barchart

Narrowing the focus, BLDR's underperformance is also apparent compared to the State Street SPDR S&P Homebuilders ETF (XHB). The exchange-traded fund has declined about 5.4% over the past year. Moreover, the ETF's 6.4% returns on a YTD basis outshine the stock's double-digit losses over the same time frame.

BLDR's underperformance stems primarily from a challenging housing market that significantly squeezed both top-line demand and operating margins. Persistent elevated interest rates and housing affordability constraints led to reduced management to lower residential starts across single-family and multi-family construction, driving lower organic sales volumes. Compounding these volume declines, commodity deflation and a shift toward smaller, value-engineered homes reduced the dollar value per housing start, resulting in pricing pressure and substantial gross margin compression.

On Jul. 30, BLDR shares fell 2.6% after reporting its Q2 results. Its adjusted EPS of $1.17 missed Wall Street expectations of $1.29. The company's revenue was $3.86 billion, falling short of Wall Street forecasts of $3.91 billion. BLDR expects full-year revenue in the range of $14 billion to $14.8 billion.

For the current fiscal year, ending in December, analysts expect BLDR's EPS to fall 54.3% to $3.15 on a diluted basis. The company's earnings surprise history is disappointing. It missed the consensus estimate in three of the last four quarters while surpassing the forecast on another occasion.

Among the 25 analysts covering BLDR stock, the consensus is a "Moderate Buy." That's based on 10 "Strong Buy" ratings, two "Moderate Buys," 11 "Holds," and two "Strong Sells."

This configuration is more bearish than a month ago, with one analyst suggesting a "Strong Sell."

On Aug. 10, The Goldman Sachs Group, Inc. (GS) analyst Charles Perron-Piche maintained a "Buy" rating on BLDR and set a price target of $90, implying a potential upside of 22.3% from current levels.

The mean price target of $80.95 represents a 10% premium to BLDR's current price levels. The Street-high price target of $100 suggests a notable upside potential of 35.9%.

On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com